Valuation: DBV Technologies

Market Cap 613M 697M 580M 526M 988M 66.92B 993M 6.94B 2.68B 34.15B 2.62B 2.56B 110B P/E 2026 *
-4.6x
P/E 2027 * -14.1x
Enterprise Value 538M 611M 508M 461M 866M 58.68B 871M 6.09B 2.35B 29.94B 2.3B 2.25B 96.23B EV / Sales 2026 *
198x
EV / Sales 2027 * 7.98x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day+6.22%
1 week-6.05%
Current month-12.18%
1 month-15.85%
3 months-25.75%
6 months-40.65%
Current year-37.91%
1 week 1.96
Extreme 1.962
2.12
1 month 1.96
Extreme 1.962
2.32
Current year 1.96
Extreme 1.962
4.14
1 year 1.48
Extreme 1.482
4.75
3 years 0.44
Extreme 0.4355
4.75
5 years 0.44
Extreme 0.4355
9.73
10 years 0.44
Extreme 0.4355
84.99
Manager TitleAgeSince
Chief Executive Officer 66 28/11/2018
Director of Finance/CFO 56 05/11/2023
Chief Operating Officer - 30/11/2023
Director TitleAgeSince
Director/Board Member 51 20/10/2015
Director/Board Member 63 20/06/2016
Director/Board Member 60 14/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.85%-6.05% - - 682M
-0.06%+1.24%+89.27%+43.05% 367B
+2.56%+6.62%+29.88%-11.02% 66.89B
-0.89%+0.39%+53.07%+193.60% 12.93B
-0.93%-0.44%-2.69%-16.04% 7.54B
+0.40%-1.93%-24.93%-11.60% 4.38B
+0.81%-1.58%-34.87%+3.48% 4.07B
-1.08%+1.04%-29.63%-15.59% 3.02B
+4.55%+6.19%-5.17%+56.05% 2.48B
-0.84%-1.50%-21.36%-28.68% 1.91B
Average +1.10%-0.41%+5.95%+23.69% 52.25B
Weighted average by Cap. +0.38%+1.54%+74.50%+37.10%

Financials

2026 *2027 *
Net sales 2.71M 3.09M 2.57M 2.33M 4.37M 296M 4.4M 30.74M 11.87M 151M 11.59M 11.34M 486M 61.95M 70.43M 58.58M 53.13M 99.78M 6.76B 100M 701M 271M 3.45B 264M 259M 11.09B
Net income -174M -198M -165M -149M -280M -18.99B -282M -1.97B -761M -9.69B -743M -727M -31.13B -126M -143M -119M -108M -203M -13.77B -204M -1.43B -552M -7.02B -538M -527M -22.57B
Net Debt -75.46M -85.8M -71.36M -64.72M -122M -8.24B -122M -854M -330M -4.2B -322M -315M -13.51B -119M -135M -113M -102M -192M -13B -193M -1.35B -521M -6.63B -508M -497M -21.31B
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change
28/09/26 €2.018 +2.85%
25/09/26 €1.962 -6.57%
24/09/26 €2.100 -1.13%
23/09/26 €2.124 +2.21%
22/09/26 €2.078 -0.86%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.022EUR
Average target price
3.637EUR
Spread / Average Target
+79.86%

Quarterly revenue - Rate of surprise